Effectiveness of BoNT-A in the treatment of migraine and its ability to repress CGRP release.
Claudio A
CA
Caputi
D019274:Botulinum Toxins, Type A / Q000494:pharmacology / Q000627:therapeutic use*; D015740:Calcitonin Gene-Related Peptide / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy* / Q000378:metabolism
D019274:Botulinum Toxins, Type A; D015740:Calcitonin Gene-Related Peptide